نتایج جستجو برای: botulinum toxin a

تعداد نتایج: 13446156  

Journal: :Anesthesiology 2007
Christiane G Frick Martina Richtsfeld Nita D Sahani Masao Kaneki Manfred Blobner J A Jeevendra Martyn

BACKGROUND Recent reports indicate increased incidence of Clostridium botulinum infections, particularly among drug abusers and tissue allograft recipients. Botulinum toxin also has potential application in biochemical warfare. The neurotoxin-induced paralysis often requires mechanical ventilation with and without muscle relaxants. The authors investigated the long-term effects of botulinum tox...

Journal: :Dermatoz 2020

Journal: :Cosmoderma 2021

Botulinum toxin for injection is a purified and diluted protein which isolated from the bacterium Clostridium botulinum . It one of most potent toxins known to humankind. C. an anaerobic Gram-positive, spore-forming present naturally in soil, plants, static water bodies, gastrointestinal tract mammals aquatic life. Different formulations are available. FDA approval these varies. This article re...

2009
Allison Brashear

Dystonia is an involuntary movement involving twisting and turning of agonist and antagonist muscles. Cervical dystonia is isolated to neck musculature. Botulinum toxin type A is a safe and effective treatment of this disabling and often painful syndrome. Three forms of botulinum toxin type A are available worldwide to treat patients with cervical dystonia. This is a review of the studies of bo...

2015
Giuseppe Brisinda Nicola Sivestrini Giuseppe Bianco Giorgio Maria Bahman Jabbari

Botulinum toxin A inhibits neuromuscular transmission. It has become a drug with many indications. The range of clinical applications has grown to encompass several neurological and non-neurological conditions. One of the most recent achievements in the field is the observation that botulinum toxin A provides benefit in diseases of the gastrointestinal tract. Although toxin blocks cholinergic n...

Journal: :Journal of clinical microbiology 1982
J C Paton A J Lawrence J I Manson

A 4-month-old boy presented with symptoms and signs characteristic of infant botulism. Examination of feces revealed Clostridium botulinum type B and type B toxin. The numbers of C. botulinum and the amount of toxin in feces were measured throughout the 4-week period in hospital. The maximum numbers and amounts were detected in a fecal specimen collected 16 days after admission: this contained ...

ژورنال: پژوهش در پزشکی 2011
اشجعی, علی, حسن زاده, محسن , محمدی, سید سجاد, کمانی, فرشته, توسلی, صبا ,

Abstract Background: Lateral sphincterotomy is the standard treatment for chronic anal fissure. In recent years, chemical sphincterotomy by several pharmacological agents, i.e. botulinum toxin, nifedipin, glyceryl trinitrate, has been used as alternative treatment. The objective of this study was to compare the results of botulinum toxin injection with lateral sphincterotomy in patients with...

Journal: :Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2004
P Bossi A Tegnell A Baka A Werner F van Loock J Hendriks H Maidhof G Gouvras

Botulism is a rare but serious paralytic illness caused by botulinum toxin, which is produced by the Clostridium botulinum. This toxin is the most poisonous substance known. It 100 000 times more toxic than sarin gas. Eating or breathing this toxin causes illness in humans. Four distinct clinical forms are described: foodborne, wound, infant and intestinal botulism. The fifth form, inhalational...

2013

Botulinum is a family of toxins produced by the anaerobic organism Clostridia botulinum. There are seven distinct serotypes designated as type A, B, C-1, D, E, F, and G. In the United States, four preparations of botulinum are commercially available, three using type A serotype and one using type B. The three formulations of botulinum toxin type A are onabotulinumtoxinA (BOTOX), abobotulinumtox...

Journal: :Disability and rehabilitation 2007
Lionel Kowal Elaine Wong Claudia Yahalom

Botulinum Toxin as a medical therapy was introduced by Dr Alan Scott more than 20 years ago. The first clinical applications of Botulinum Toxin type A (BT-A) were for the treatment of strabismus and for periocular spasms. Botulinum Toxin type A is often effective in small to moderate angle convergent strabismus (esotropia) of any cause, and may be an alternative to surgery in these cases. Botul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید